[1. Workowski KA, Berman SM, Douglas JM. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008; 148:606-13.10.7326/0003-4819-148-8-200804150-00005]Search in Google Scholar
[2. Hyde JE. Drug-resistant malaria- an insight. Febs J. 2007; 274:4688-98.10.1111/j.1742-4658.2007.05999.x]Search in Google Scholar
[3. Aaerestrup FM, Aidara-Kane A, Cars O, Heddini A, Chang S, So A. The evolving threat of antimicrobial resistance - options for action. Geneva, Switzerland: WHO. 2012]Search in Google Scholar
[4. Leung E, Weil DE, Raviglione M, Nakafani H, et al. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ. 2001; 89:390-2.10.2471/BLT.11.088435]Search in Google Scholar
[5. Norrby SR, Nord CE, Finch R, European Society of Clinical Microbiology and Infectious Diseases. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis. 2005; 5:115-9.10.1016/S1473-3099(05)70086-4]Open DOISearch in Google Scholar
[6. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat. 2000; 3:303-311.10.1054/drup.2000.016711498398]Search in Google Scholar
[7. Bronzwaer S, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al. The relationship between antimicrobial use and antimicrobial resistance in Europe. Emerg Infect Dis. 2002; 8: 278-82.10.3201/eid0803.010192273247111927025]Open DOISearch in Google Scholar
[8. Cassell GH, Mekalanos J. Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. JAMA. 2001; 285:601-5.10.1001/jama.285.5.60111176866]Search in Google Scholar
